Bio-gate AG (BIG1) - Total Liabilities
Based on the latest financial reports, Bio-gate AG (BIG1) has total liabilities worth €2.16 Million EUR (≈ $2.52 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BIG1 operating cash flow to assess how effectively this company generates cash.
Bio-gate AG - Total Liabilities Trend (2020–2024)
This chart illustrates how Bio-gate AG's total liabilities have evolved over time, based on quarterly financial data. See BIG1 net asset value for net asset value and shareholders' equity analysis.
Bio-gate AG Competitors by Total Liabilities
The table below lists competitors of Bio-gate AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nikola Corp
NASDAQ:NKLA
|
USA | $656.80 Million |
|
Krakatoa Resources Ltd
AU:KTA
|
Australia | AU$356.39K |
|
Loyal Solutions AS
ST:LOYAL
|
Sweden | Skr53.19 Million |
|
WF Holding Limited Ordinary Shares
NASDAQ:WFF
|
USA | $3.47 Million |
|
XiDeLang Holdings Ltd
KLSE:5156
|
Malaysia | RM53.07 Million |
|
Llama Group S.A.
PA:ALLAM
|
France | €18.95 Million |
|
Palred Technologies Limited
NSE:PALREDTEC
|
India | Rs727.38 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Bio-gate AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bio-gate AG (BIG1) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bio-gate AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bio-gate AG (2020–2024)
The table below shows the annual total liabilities of Bio-gate AG from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €2.16 Million ≈ $2.52 Million |
+19.42% |
| 2023-12-31 | €1.81 Million ≈ $2.11 Million |
-8.07% |
| 2022-12-31 | €1.97 Million ≈ $2.30 Million |
+36.40% |
| 2021-12-31 | €1.44 Million ≈ $1.69 Million |
-18.06% |
| 2020-12-31 | €1.76 Million ≈ $2.06 Million |
-- |
About Bio-gate AG
Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating which protects the surfaces of medical implants against bacterial colonization; and MicroSilver BG, an elemental microporous silver additive. It distributes its products to veterinarians and veterinary clinics. The company was incorporated in 2005 and is bas… Read more